WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration has warned Abbott Laboratories (ABT) over manufacturing violations found at a company plant in Illinois, according to a letter posted to the FDA's Web site Tuesday. The FDA said it inspected...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FDA Warns Abbott Over Manufacturing Violations At Plant
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account